Bakkt Holdings, Inc.
NYSE:BKKTSoftware - Infrastructure
+$0.09 today
- Market cap
- $124.10M
- Beta
- 5.86
- P/E (TTM)
- -1.0
- EPS (TTM)
- -$9.46
Volume 2.16M
Average 1.62M
BKKT Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Bakkt Holdings, Inc.NYSE: BKKT
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How BKKT compares with its peers on the latest reported figures
- BKKT's LTM Mar 2026 research & development of $0 is the 7th highest of the 11 companies compared; the peer median is $8.72M.
- Research & development amounts to 0.0% of revenue for BKKT, versus a peer median of 13.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $57.04M | +6.2% | -1.5% | 35.2% | |
| LTM Mar 2026 | $32.29M | -2.1% | -26.5% | 27.4% | |
| LTM Mar 2026 | $21.26M | -12.7% | -21.9% | 23.6% | |
| LTM Mar 2026 | $14.11M | -20.5% | -7.8% | 28.5% | |
| LTM Mar 2026 | $13.93M | +33.8% | -27.7% | 197.0% | |
| LTM Mar 2026 | $3.52M | +91.7% | -39.9% | 3.2% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | -100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding BKKT) | $8.72M | -2.1% | -24.2% | 13.4% | |
Competitors are the stored peer set for BKKT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 37.25M | 56.22M | 780.14M | 3.49B | 2.34B |
| Cost of Revenue | 0 | 1.66M | 718.51M | 3.4B | 2.31B |
| Gross Profit | 37.25M | 54.57M | 61.63M | 87.01M | 26.85M |
| Gross Margin | 100.0% | 97.1% | 7.9% | 2.5% | 1.1% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 168.54M | 203.03M | 166.65M | 144.24M | 122.57M |
| Operating Expenses | 201.4M | 2.07B | 289.52M | 179.93M | 168.57M |
| Depreciation & Amortization | 14.52M | 25.35M | 13.93M | 343K | 607K |
| EBITDA | (134.75M) | (151.97M) | (114.29M) | (83.36M) | (97.1M) |
| EBITDA Margin | -361.7% | -270.3% | -14.6% | -2.4% | -4.2% |
| Operating Income | (164.14M) | (2.02B) | (227.89M) | (92.92M) | (141.71M) |
| Operating Margin | -440.6% | -3590.8% | -29.2% | -2.7% | -6.1% |
| Interest Income | 11K | 1.88M | 4.34M | 4.32M | 0 |
| Interest Expense | 247K | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (78.3M) | 17.66M | 2.52M | (10.36M) | 44.01M |
| Income Before Tax | (242.44M) | (2B) | (225.37M) | (103.28M) | (97.71M) |
| Pre-Tax Margin | -650.8% | -3559.4% | -28.9% | -3.0% | -4.2% |
| Income Tax Expense | 11.95M | (11.32M) | 444K | 170K | (49K) |
| Net Income | (133.55M) | (578.11M) | (74.85M) | (46.66M) | (107.21M) |
| Net Margin | -358.5% | -1028.2% | -9.6% | -1.3% | -4.6% |
| EPS (Basic) | (4.24) | (203.08) | (21.01) | (7.97) | (15.71) |
| EPS (Diluted) | (4.24) | (203.08) | (21.01) | (7.97) | (15.71) |
| Weighted Avg Shares | 57.16M | 2.85M | 3.56M | 5.86M | 6.83M |
| Weighted Avg Shares (Diluted) | 57.16M | 2.85M | 3.56M | 5.86M | 6.83M |
Bakkt Holdings, Inc.
NYSE:BKKT
Intrinsic Alpha fair value
Locked
Current Price
$2.75
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.